共 50 条
- [33] Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, Reduces the Risk of Cardiovascular and Renal Disease as Assessed by Steno Risk Engines in Adults With Type 1 Diabetes JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 674 - 675
- [35] Risk Factors for Cardiovascular Disease in Type 1 Diabetes DIABETES, 2016, 65 (05) : 1370 - 1379
- [37] Cardiovascular disease risk in type 1 diabetes Reply Lancet Diabetes & Endocrinology, 2015, 3 (05): : 317 - 317
- [38] Cardiovascular risk perceptibn in patients with type 1 diabetes DIABETES, 2004, 53 : A223 - A224
- [39] Menopause and Cardiovascular Risk in Women with Type 1 Diabetes DIABETES, 2016, 65 : A122 - A122
- [40] Type 1 diabetes, metabolic syndrome and cardiovascular risk METABOLISM-CLINICAL AND EXPERIMENTAL, 2014, 63 (02): : 181 - 187